Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC.
Novartis
Novartis
AstraZeneca
Merck Sharp & Dohme LLC
Hoffmann-La Roche
AstraZeneca
Pfizer
Alexandria University
Radboud University Medical Center
Samsung Medical Center
AstraZeneca
West China Hospital
Radboud University Medical Center
Pfizer
Genentech, Inc.
Jiangsu Simcere Pharmaceutical Co., Ltd.
Odense University Hospital
Bristol-Myers Squibb
Chonnam National University Hospital
Zhejiang Cancer Hospital
Peter MacCallum Cancer Centre, Australia
Radboud University Medical Center
Laval University
AstraZeneca
Centre Georges Francois Leclerc
Bristol-Myers Squibb
Fuda Cancer Hospital, Guangzhou
Catholic University of the Sacred Heart
Boehringer Ingelheim
China Medical University, China
Quadras Scientific Solutions
Catalysis SL
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Boehringer Ingelheim
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Celgene
Shandong Cancer Hospital and Institute
GlaxoSmithKline
Fujian Medical University Union Hospital
VA Greater Los Angeles Healthcare System
University of Kansas Medical Center
Weill Medical College of Cornell University
AstraZeneca
Hoffmann-La Roche
Fundacion Clinic per a la Recerca Biomédica
Hoffmann-La Roche
Hoffmann-La Roche
University of Zurich
Novartis
Fox Chase Cancer Center
AstraZeneca